Spanish Validation of the MAP-SRTwo Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia

  1. María Paz García-Portilla 1
  2. Leticia García-Álvarez 1
  3. Lorena de la Fuente-Tomás 1
  4. Francesco Dal Santo 2
  5. Ángela Velasco 1
  6. Leticia González-Blanco 1
  7. Paula Zurrón-Madera 1
  8. Eduardo Fonseca-Pedrero 3
  9. María Teresa Bobes-Bascarán 1
  10. Pilar A Sáiz 1
  11. Julio Bobes 1
  1. 1 Universidad de Oviedo
    info

    Universidad de Oviedo

    Oviedo, España

    ROR https://ror.org/006gksa02

  2. 2 Servicio de Salud del Principado de Asturias (SESPA)
    info

    Servicio de Salud del Principado de Asturias (SESPA)

    Oviedo, España

  3. 3 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

Mostrar afiliaciones +
Revista:
Psicothema

ISSN: 0214-9915,  1886-144X

Año de publicación: 2021

Título del ejemplar: Monográfico Mariano Yela

Volumen: 33

Número: 3

Páginas: 473-480

Tipo: Artículo

DOI: 10.7334/PSICOTHEMA2020.457 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Psicothema

Objetivos de desarrollo sostenible

Resumen

Background: There is little research on self-reported negative symptomatology measures in schizophrenia. The aims of this study were to validate the Spanish version of the Motivation and Pleasure Scale-Self-Report (MAP-SR) and determine the concordance between patient-reported outcome measures for reflecting the severity of negative symptoms of schizophrenia and clinician-rated outcome measures. Method: A sample of 174 subjects who completed the MAP-SR and 104 who completed the Self-Evaluation of Negative Symptoms (SNS) were analyzed. The clinician-reported outcome measures (CROMs) were the Spanish versions of the Clinical Assessment Interview for Negative Symptoms (CAINS) and the Positive and Negative Syndrome Scale (PANSS), while the patient-reported outcome measures (PROMs) were MAP-SR and SNS. Cronbach’s a, bivariate analyses and Lin’s concordance correlation coefficient (CCC) were calculated. Results: The Spanish version of the MAP-SR demonstrated excellent reliability (Cronbach’s α=.923). Its correlation coefficients were higher with CAINS [CAINS-Total: r=.608, p<.005; CAINS-Motivation and Pleasure subscale(CAINS-MAP): r=.662, p<.005] than with PANSS negative scales [PANSS-Negative scale(PANSS-N): r=.393, p<.005; PANSS-Marder Negative Factor(PANSS-MNF): r=.478, p<.005]. Finally, concordance between clinician and patient ratings was low in all cases, varying from a CCC of 0.661 to .392. Conclusions: We found poor concordance between patient and clinician ratings, hence we believe that the two evaluations are not mutually exclusive but complementary

€ Ver financiación

Información de financiación

This work was partly supported by the Government of the Principality of Asturias PCTI-2018-2022 IDI/2018/235, Fundación para la Investigación e Innovación Biosanitaria del Principado de Asturias (FINBA), the CIBERSAM, the Instituto de Salud Carlos III (grants PI13/02263 and PI16/01761 to Dr. Julio Bobes), and Fondos Europeos de Desarrollo Regional (FEDER).

Financiadores

Referencias bibliográficas

  • Alonso, J., Prieto, L., & Antó, J. M. (1995). The Spanish version of the SF36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results. Medicina Clínica (Barc), 104, 771-776.
  • Arango, C., Kirkpatrick, B., Buchanan, R. W., & Carpenter, WT.Jr. (1998). El síndrome deficitario: un dominio dentro de la esquizofrenia [The deficit syndrome: A domain of schizophrenia]. Actas Luso Españolas de Neurología, Psiquiatría y Ciencias Afi nes, 26, 180-186.
  • Bobes, J., Arango, C., García-García, M., Rejas, J., & Group, C. S. C. (2010). Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: Findings from the CLAMORS study. Journal of Clinical Psychiatry, 71(3), 280-286. https://doi.org/10.4088/JCP.08m04250yel
  • Bobes, J., García-Portilla, M. P., Bascarán, M. T., Sáiz, P. A., & Bousono, M. (2007). Quality of life in schizophrenic patients. Dialogues in Clinical Neuroscience, 9(2), 215-226. https://doi.org/10.31887/ DCNS.2007.9.2/jbobes
  • Brady, R. O., Jr., Gonsalvez, I., Lee, I., Ongur, D., Seidman, L. J., Schmahmann, J. D., Eack, S.M., Keshavan, M.S., Pascual-Leone, A., & Halko, M. A. (2019). Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia. The American Journal of Psychiatry, 176(7), 512-520. https://doi.org/10.1176/appi.ajp.2018.18040429
  • Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., & Callaghan, E. O. (1996). Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatrica Scandinavica, 94(2), 118-124. https:// doi.org/10.1111/j.1600-0447.1996.tb09835.x
  • Carpenter, W. T., Jr., Heinrichs, D. W., & Wagman, A. M. (1988). Deficit and nondeficit forms of schizophrenia: The concept. The American Journal of Psychiatry, 145(5), 578-583. https://doi.org/10.1176/ajp.145.5.578
  • Dollfus, S., Mach, C., & Morello, R. (2016). Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms. Schizophrenia Bulletin, 42(3), 571-578. https://doi.org/10.1093/schbul/sbv161
  • Engel, M., & Lincoln, T. M. (2016). Motivation and Pleasure ScaleSelf-Report (MAP-SR): Validation of the German version of a selfreport measure for screening negative symptoms in schizophrenia. Comprehensive Psychiatry, 65, 110-115. https://doi.org/10.1016/j. comppsych.2015.11.001
  • Engel, M., & Lincoln, T. M. (2017). Concordance of selfand observerrated motivation and pleasure in patients with negative symptoms and healthy controls. Psychiatry Research, 247, 1-5. https://doi. org/10.1016/j.psychres.2016.11.013
  • Fervaha, G., Takeuchi, H., Agid, O., Lee, J., Foussias, G., & Remington, G. (2015). Determinants of patient-rated and clinician-rated illness severity in schizophrenia. Journal of Clinical Psychiatry, 76(7), 924- 930. https://doi.org/10.4088/JCP.14m09128
  • García-Alvarez, L., García-Portilla, M. P., Sáiz, P. A., Fonseca-Pedrero, E., Bobes-Bascarán, M. T., Gomar, J., Muñiz, J., & Bobes, J. (2018). Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia. Revista de Psiquiatría y Salud Mental, 11(3), 169-175. https://doi.org/10.1016/j.rpsmen.2018.03.002
  • García-Álvarez, L., Martínez-Cao, C., Bobes-Bascarán, T., Portilla, A., Courtet, P., de la Fuente-Tomás, L., Velasco, Á., González-Blanco, L., Zurrón-Madera, P., Fonseca-Pedrero, E., Sáiz, P. A., García-Portilla, M. P., & Bobes, J. (2020). Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia. Revista de Psiquiatría y Salud Mental, S1888- 9891(20)30036-7. https://doi.org/10.1016/j.rpsm.2020.04.011
  • García-Portilla, M. P., & Bobes, J. (2013). Ante el nuevo reto de identificar el síndrome negativo de la esquizofrenia [The new challenge in identifying the negative syndrome of schizophrenia]. Revista de Psiquiatría y Salud Mental, 6(4), 141-143. https://doi.org/10.1016/j. rpsm.2013.09.002
  • García-Portilla, M. P., García-Alvarez, L., Sáiz, P. A., Al-Halabi, S., Bobes-Bascarán, M. T., Bascarán, M. T., Muñiz, J., & Bobes, J. (2015). Psychometric evaluation of the negative syndrome of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 265(7), 559-566. https://doi.org/10.1007/s00406-015-0595-z
  • Hervochon, C., Bourgeois, V., Rotharmel, M., Duboc, J. B., Le Goff, B., Quesada, P., Campion, D., Dollfus, S., & Guillin, O. (2018). [Validation of the French version of the self-evaluation of negative symptoms (SNS)]. Encephale, 44(6), 512-516. https://doi.org/ 10.1016/j.encep. 2017.10.002
  • IBM Corp. (2016). IBM SPSS Statistics for Windows (Version 24.0) [Computer software]. IBM Corp.
  • Kirkpatrick, B., Strauss, G. P., Nguyen, L., Fischer, B. A., Daniel, D. G., Cienfuegos, A., & Marder, S. R. (2011). The brief negative symptom scale: Psychometric properties. Schizophrenia Bulletin, 37(2), 300-305. https://doi.org/10.1093/schbul/sbq059
  • Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., & Reise, S. P. (2013). The Clinical Assessment Interview for Negative Symptoms (CAINS): Final development and validation. The American Journal of Psychiatry, 170(2), 165-172. https://doi.org/10.1176/appi.ajp.2012.12010109
  • Lehman, A. F. (1983). The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Evaluation and Program Planning, 6(2), 143-151. https://doi.org/10.1016/0149- 7189(83)90028-9
  • Li, Y., Li, W. X., Zou, Y. M., Yang, Z. Y., Xie, D. J., Yang, Y., Lui, S. S. Y., Strauss, G.P., Cheung, E.F.C., & Chan, R. C. K. (2018). Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms. Schizophrenia Research, 202, 248- 253. https://doi.org/10.1016/j.schres.2018.07.005
  • Lin, L. I. (1989). A concordance correlation coefficient to evaluate reproducibility. Biometrics, 45(1), 255-268. https://doi.org/10.2307/ 2532051
  • Llerena, K., Park, S. G., McCarthy, J. M., Couture, S. M., Bennett, M. E., & Blanchard, J. J. (2013). The Motivation and Pleasure Scale-Self-Report (MAP-SR): Reliability and validity of a self-report measure of negative symptoms. Comprehensive Psychiatry, 54(5), 568-574. https://doi. org/10.1016/j.comppsych.2012.12.001
  • McBride, G.B. (2005). A proposal for strength-of-agreement criteria for Lin’s Concordance Correlation Coeffi cient. National Institute of Water & Atmospheric Reseach Ltd. https://www.medcalc.org/download/pdf/ McBride2005.pdf
  • MedCalc Software (2016). MedCalc Statistical Software (Version 16.4.3) [Computer software]. MedCalc Software bvba. https://www.medcalc.org
  • Marder, S.R., Davis, J.M., & Chouinard, G. (1997). The effects of risperidone on the fi ve dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. The Journal of Clinical Psychiatry, 58, 538-546.
  • Menéndez-Miranda, I., García-Portilla, M. P., García-Alvarez, L., Arrojo, M., Sánchez, P., Sarramea, F., Gomar, J., Bobes-Bascarán, M.T. Sierra, P., Sáiz, P.A., & Bobes, J. (2015). Predictive factors of functional capacity and real-world functioning in patients with schizophrenia. European Psychiatry, 30(5), 622-627. https://doi.org/10.1016/j. eurpsy.2014.12.011
  • Peralta, V., & Cuesta, M. J. (1994). Validación de la Escala de los Síndromes Positivo y Negativo (PANSS) en una muestra de esquizofrénicos españoles [Validation of the Positive and Negative Syndrome Scale (PANSS) in a sample of Spanish patients with schizophrenia]. Actas Luso-Españolas de Neurología, Psiquiatría y Ciencias Afi nes, 22, 171- 177.
  • Richter, J., Hesse, K., Eberle, M. C., Eckstein, K. N., Zimmermann, L., Schreiber, L., Burmeister, C.P., Wildgruber, D., & Klingberg, S. (2019). Self-assessment of negative symptoms Critical appraisal of the motivation and pleasure-Self-report’s (MAP-SR) validity and reliability. Comprehensive Psychiatry, 88, 22-28. https://doi.org/ 10.1016/j.comppsych.2018.10.007
  • Salagre, E., Arango, C., Artigas, F., Ayuso-Mateos, J. L., Bernardo, M., Castro-Fornieles, J., Bobes, J., Desco, M., Fañanás, L., GonzálezPinto, A., Haro, J.M., Leza, J.C., Mckenna, P.J., Meana, J.J., Menchón, J.M., Micó, J.A., Palomo, T., Pazos, A., Pérez, V., . . . Vieta, E. (2019). CIBERSAM: Ten years of collaborative translational research in mental disorders. Revista de Psiquiatría y Salud Mental, 12(1), 1-8. https://doi. org/10.1016/j.rpsm.2018.10.001
  • Sarro, S., Dueñas, R. M., Ramírez, N., Arranz, B., Martínez, R., Sánchez, J. M., González, J.M., Salo, L., Miralles, L., & San, L. (2004). Crosscultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia. Schizophrenia Research, 68(2-3), 349-356. https://doi.org/10.1016/S0920-9964(02)00490-5
  • Song, J., Borlido, C., De Luca, V., Burton, L., & Remington, G. (2019). Patient versus rater evaluation of symptom severity in treatment resistant schizophrenia receiving clozapine. Psychiatry Research, 274, 409-413. https://doi.org/10.1016/j.psychres.2019.02.050
  • The WHOQOL Group (1995). The World Health Organization Quality of Life Assessment (the WHOQOL): Position paper from the World Health Organization. Social Science & Medicine, 41, 1403-1409. https://doi. org/10.1016/0277-9536(95)00112-K
  • Valiente-Gómez, A., Mezquida, G., Romaguera, A., Vilardebo, I., Andrés, H., Granados, B., Larrubia, J., Pomarol-Clotet, E., McKenna, P.J., Sarró, S., & Bernardo, M. (2015). Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS). Schizophrenia Research, 166(1-3), 104-109. https://doi.org/10.1016/j. schres.2015.06.006
  • Weldring, T., & Smith, S. M. S. (2013). Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Services Insight, 6, 61-68. https://doi.org/10.4137/HSI.S11093
Fuente de los datos: Dialnet